Skip to content

Clinical trials

Phase 2 Arterial Occlusive Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arterial Occlusive Diseases Phase: Phase 2 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20111
20121
20131
20141
20161
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AnGes USA, Inc.2
Duke University2
ARCA Biopharma, Inc.1
AstraZeneca1
Fluoropharma, Inc.1
Siemens Healthineers Endovascular Robotics, Inc.1
Tufts Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arterial Occlusive Diseases9
Vascular Diseases6
Cardiovascular Diseases5
Arteriosclerosis4
Heart Diseases4
Peripheral Vascular Diseases4
Coronary Artery Disease3
Coronary Disease3
Myocardial Ischemia3
Peripheral Arterial Disease3

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.